Spirochetal Infections of the Nervous System

Neurology and General Medicine

Volumn , Issue , 2008, Pages 789-802

  Halperin, John J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882897541     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044306707-5.50044-4     Document Type: Chapter

References (116)

1. Tramont E Treponema pallidum (syphilis). Principles and Practice of Infectious Diseases 2000, Vol 2:2474. Churchill Livingstone, Philadelphia. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
2. Anonymous Primary and secondary syphilis-United States, 2003-2204. MMWR Morb Mortal Wkly Rep 2006, 55:269.
3. Larsen SA, Norris SJ, Pope V Treponema and other host-associated spirochetes. Manual of Clinical Microbiology 1999, 759. ASM Press, Washington, DC, . 7th Ed. P.R. Murray, E.J. Baron, M.A. Pfaller (Eds.).
4. Fraser CM, Norris SJ, Weinstock GM, et al. Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science 1998, 281:375.
5. Hanrahan JP, Benach JL, Coleman JL, et al. Incidence and cumulative frequency of endemic Lyme disease in a community. J Infect Dis 1984, 150:489.
6. Anonymous Sexually transmitted diseases treatment guidelines, 2006. MMWR Morb Mortal Wkly Rep 2006, 55:22.
7. Libois A, De Wit S, Poll B, et al. HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis 2007, 34:141.
8. Marra C, Tantalo L, Maxwell C, et al. Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV infected individuals. Neurology 2004, 63:85.
9. Luger AF, Schmidt BL, Kaulich M Significance of laboratory findings for the diagnosis of neurosyphilis. Int J STD AIDS 2000, 11:224.
10. Davis LE, Schmitt JW Clinical significance of cerebrospinal fluid tests for neurosyphilis. Ann Neurol 1989, 25:50.
11. Marra CM, Critchlow CW, Hook EW, et al. Cerebrospinal fluid treponemal antibodies in untreated early syphilis. Arch Neurol 1995, 52:68.
12. Carey LA, Glesby MJ, Mundy LM, et al. Lumbar puncture for evaluation of latent syphilis in hospitalized patients: high prevalence of cerebrospinal fluid abnormalities unrelated to syphilis. Arch Intern Med 1995, 155:1657.
13. Roos KL Pearls and pitfalls in the diagnosis and management of central nervous system infectious diseases. Semin Neurol 1998, 18:185.
14. Lowhagen GB Syphilis: test procedures and therapeutic strategies. Semin Dermatol 1990, 9:152.
15. Marra CM, Castro CD, Kuller L, et al. Mechanisms of clearance of Treponema pallidum from the CSF in a nonhuman primate model. Neurology 1998, 51:957.
16. Moskophidis M, Peters S Comparison of intrathecal synthesis of Treponema pallidum-specific IgG antibodies and polymerase chain reaction for the diagnosis of neurosyphilis. Zentralbl Bakteriol 1996, 283:295.
17. Muller F, Moskophidis M, Schmitz H Intrathecal synthesis of specific IgG in syphilitic patients with human immunodeficiency virus 1 infection. J Neurol 1988, 235:252.
18. Rockwell DH, Yobs AR, Moore MB The Tuskegee study of untreated syphilis: the 30th year of observation. Arch Intern Med 1964, 114:792.
19. Clark EG, Danbolt N The Oslo study of the natural course of untreated syphilis. Med Clin North Am 1964, 48:613.
20. Alam F, Yasutomi H, Fukuda H, et al. Diffuse cerebral white matter T2-weighted hyperintensity: a new finding of general paresis. Acta Radiol 2006, 47:609.
21. Flood JM, Weinstock HS, Guroy ME, et al. Neurosyphilis during the AIDS epidemic, San Francisco, 1985-1992. J Infect Dis 1998, 177:931.
22. Sanchez PJ, Wendel GD, Grimprel E, et al. Evaluation of molecular methodologies and rabbit infectivity testing for the diagnosis of congenital syphilis and neonatal central nervous system invasion by Treponema pallidum. J Infect Dis 1993, 167:148.
23. Sanchez PJ, Wendel GD, Norgard MV IgM antibody to Treponema pallidum in cerebrospinal fluid of infants with congenital syphilis. Am J Dis Child 1992, 146:1171.
24. Jay CA Treatment of neurosyphilis. Curr Treat Options Neurol 2006, 8:185.
25. Mohr JA, Griffiths W, Jackson R, et al. Neurosyphilis and penicillin levels in cerebrospinal fluid. JAMA 1976, 236:2208.
26. Berry CD, Hooton TM, Collier AC, et al. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 1987, 316:1587.
27. Polnikorn N, Witoonpanich R, Vorachit M, et al. Penicillin concentrations in cerebrospinal fluid after different treatment regimens for syphilis. Br J Venereol Dis 1980, 56:363.
28. Marra CM, Boutin P, McArthur JC, et al. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis 2000, 30:540.
29. Marra CM, Slatter V, Tartaglione TA, et al. Evaluation of aqueous penicillin G and ceftriaxone for experimental neurosyphilis. J Infect Dis 1992, 165:396.
30. Schofer H, Vogt HJ, Milbradt R Ceftriaxone for the treatment of primary and secondary syphilis. Chemotherapy 1989, 35:140.
31. Shann S, Wilson J Treatment of neurosyphilis with ceftriaxone. Sex Transm Infect 2003, 79:415.
32. Gordon SM, Eaton ME, George R, et al. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med 1994, 331:1469.
33. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection: the Syphilis and HIV Study Group. N Engl J Med 1997, 337:307.
34. Steere AC, Malawista SE, Hardin JA, et al. Erythema chronicum migrans and Lyme arthritis: the enlarging clinical spectrum. Ann Intern Med 1977, 86:685.
35. Afzelius A Verhandlugen der dermatorischen Gesellschaft zu Stockholm. Arch Derm Syphiligr 1910, 101:404.
36. Reik L, Steere AC, Bartenhagen NH, et al. Neurologic abnormalities of Lyme disease. Medicine (Baltimore) 1979, 58:281.
37. Garin, Bujadoux Paralysie par les tiques. J Med Lyon 1922, 71:765.
38. Bannwarth A Chronische lymphocytare meningitis, entzundliche polyneuritis und "rheumatismus". Arch Psychiatr Nervenkr 1941, 113:284.
39. Burgdorfer W, Barbour AG, Hayes SF, et al. Lyme disease: a tick-borne spirochetosis?. Science 1982, 216:1317.
40. Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med 1983, 308:733.
41. Benach JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 1983, 308:740.
42. Asbrink E, Hederstedt B, Hovmark A The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm Venereol 1984, 64:506.
43. Baranton G, Postic D, Saint GI, et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 1992, 42:378.
44. Rosa PA Microbiology of Borrelia burgdorferi. Semin Neurol 1997, 17:5.
45. Wilson ML, Telford SR, Piesman J, et al. Reduced abundance of immature Ixodes dammini (Acari: Ixodidae) following elimination of deer. J Med Entomol 1988, 25:224.
46. Hayes EB, Piesman J How can we prevent Lyme disease?. N Engl J Med 2003, 348:2424.
47. Surveillance for Lyme disease-United States, 1992-1998. MMWR Morb Mortal Wkly Rep 2000, 49:1.
48. Gerber MA, Shapiro ED, Burke GS, et al. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med 1996, 335:1270.
49. Atlas E, Novak SN, Duray PH, et al. Lyme myositis: muscle invasion by Borrelia burgdorferi. Ann Intern Med 1988, 109:245.
50. Schoenen J, Sianard GJ, Carpentier M, et al. Myositis during Borrelia burgdorferi infection (Lyme disease). J Neurol Neurosurg Psychiatry 1989, 52:1002.
51. Reimers CD, de Koning J, Neubert U, et al. Borrelia burgdorferi myositis: report of eight patients. J Neurol 1993, 240:278.
52. Carvounis PE, Mehta AP, Geist CE Orbital myositis associated with Borrelia burgdorferi (Lyme disease) infection. Ophthalmology 2004, 111:1023.
53. Holmgren AR, Matteson EL Lyme myositis. Arthritis Rheum 2006, 54:2697.
54. Acog Committee Opinion Lyme disease during pregnancy. Committee on Obstetrics: Maternal and Fetal Medicine. Number 99, November 1991. Int J Gynaecol Obstet 1992, 39:59.
55. Strobino BA, Williams CL, Abid S, et al. Lyme disease and pregnancy outcome: a prospective study of two thousand prenatal patients. Am J Obstet Gynecol 1993, 169:367.
56. Pachner AR, Steere AC The triad of neurologic manifestations of Lyme disease. Neurology 1985, 35:47.
57. Luft BJ, Steinman CR, Neimark HC, et al. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA 1992, 267:1364.
58. Keller TL, Halperin JJ, Whitman M PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology 1992, 42:32.
59. Logigian EL, Steere AC Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA 1992, 267:1364.
60. Karlsson M, Hovind HK, Svenungsson B, et al. Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J Clin Microbiol 1990, 28:473.
61. Kan L, Sood SK, Maytal J Pseudotumor cerebri in Lyme disease: a case report and literature review. Pediatr Neurol 1998, 18:439.
62. Jacobson DM, Frens DB Pseudotumor cerebri syndrome associated with Lyme disease. Am J Ophthalmol 1989, 107:81.
63. Rothermel H, Hedges TR, Steere AC Optic neuropathy in children with Lyme disease. Pediatrics 2001, 108:477.
64. Ackermann R, Rehse KB, Gollmer E, et al. Chronic neurologic manifestations of erythema migrans borreliosis. Ann N Y Acad Sci 1988, 539:16.
65. Halperin JJ, Volkman DJ, Wu P Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 1991, 41:1571.
66. Kalina P, Decker A, Kornel E, et al. Lyme disease of the brainstem. Neuroradiology 2005, 47:903.
67. Garcia-Monco JC, Fernandez-Villar B, Benach JL Adherence of the Lyme disease spirochete to glial cells and cells of glial origin. J Infect Dis 1989, 160:497.
68. Garcia Monco JC, Fernandez Villar B, Rogers RC, et al. Borrelia burgdorferi and other related spirochetes bind to galactocerebroside. Neurology 1992, 42:1341.
69. Peter L, Jung J, Tilikete C, et al. Opsoclonus-myoclonus as a manifestation of Lyme disease. J Neurol Neurosurg Psychiatry 2006, 77:1090.
70. Halperin JJ: Stroke in Lyme disease. In Caplan L (ed): Uncommon Causes of Stroke. 2nd Ed. Cambridge University Press, Cambridge (in press).
71. Sibony P, Halperin J, Coyle P, et al. Reactive Lyme serology in patients with optic neuritis and papilledema. J Neuroophthalmol 2005, 25:71.
72. Halperin JJ, Luft BJ, Anand AK, et al. Lyme neuroborreliosis: central nervous system manifestations. Neurology 1989, 39:753.
73. Logigian EL, Kaplan RF, Steere AC Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990, 323:1438.
74. Krupp LB, Fernquist S, Masur D, Halperin JJ Cognitive impairment in Lyme disease. Neurology 1990, 40:304.
75. Halperin JJ, Krupp LB, Golightly MG, Volkman DJ Lyme borreliosis-associated encephalopathy. Neurology 1990, 40:1340.
76. Halperin JJ, Pass HL, Anand AK, et al. Nervous system abnormalities in Lyme disease. Ann N Y Acad Sci 1988, 539:24.
77. Kaplan RF, Jones-Woodward L, Workman K, et al. Neuropsychological deficits in Lyme disease patients with and without other evidence of central nervous system pathology. Appl Neuropsychol 1999, 6:3.
78. Logigian EL, Kaplan RF, Steere AC Successful treatment of Lyme encephalopathy with intravenous ceftriaxone. J Infect Dis 1999, 180:377.
79. Krupp LB, LaRocca NG, Luft BJ, Halperin JJ Comparison of neurologic and psychologic findings in patients with Lyme disease and chronic fatigue syndrome. Neurology 1989, 39:144.
80. Coyle PK, Krupp LB, Doscher C, Amin K Borrelia burgdorferi reactivity in patients with severe persistent fatigue who are from a region in which Lyme disease is endemic. Clin Infect Dis 1994, 18:S24.
81. Elkins LE, Pollina DA, Scheffer SR, et al. Psychological states and neuropsychological performances in chronic Lyme disease. Appl Neuropsychol 1999, 6:19.
82. Gaudino EA, Coyle PK, Krupp LB Post-Lyme syndrome and chronic fatigue syndrome: neuropsychiatric similarities and differences. Arch Neurol 1997, 54:1372.
83. Hajek T, Libiger J, Janovska D, et al. Clinical and demographic characteristics of psychiatric patients seropositive for Borrelia burgdorferi. Eur Psychiatry 2006, 21:118.
84. Halperin JJ Facial nerve palsy associated with Lyme disease. Muscle Nerve 2003, 28:516.
85. Eiffert H, Karsten A, Schlott T, et al. Acute peripheral facial palsy in Lyme disease-a distal neuritis at the infection site. Neuropediatrics 2004, 35:267.
86. Halperin JJ, Shapiro ED, Logigian EL, et al. Practice parameter: treatment of nervous system Lyme disease. Neurology 2007, 69:91.
87. Hopf HC Peripheral neuropathy in acrodermatitis chronica atrophicans. J Neurol Neurosurg Psychiatry 1975, 38:452.
88. Halperin JJ, Dattwyler RJ Peripheral nervous system manifestations of Lyme disease. Neurology 1989, 39(suppl 1):234.
89. Halperin JJ, Luft BJ, Volkman DJ, et al. Lyme neuroborreliosis-peripheral nervous system manifestations. Brain 1990, 113:1207.
90. England JD, Bohm RP, Roberts ED, et al. Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann Neurol 1997, 41:375.
91. Sterman AB, Nelson S, Barclay P Demyelinating neuropathy accompanying Lyme disease. Neurology 1982, 32:1302.
92. Lopez de Munain A, Espinal Valencia JB, Marti-Masso JF, et al. Antibodies to Borrelia burgdorferi in Guillain-Barré syndrome. Lancet 1990, 335:1168.
93. Shapiro EE Guillain-Barré syndrome in a child with serologic evidence of Borrelia. Pediatr Infect Dis J 1998, 17:264.
94. Halperin J, Logigian E, Finkel M, et al. Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Neurology 1996, 46:619.
95. Golightly MG Laboratory considerations in the diagnosis and management of Lyme borreliosis. Am J Clin Pathol 1993, 99:168.
96. Bakken LL, Case KL, Callister SM, et al. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. JAMA 1992, 268:891.
97. Schwartz BS, Goldstein MD, Ribeiro JM, et al. Antibody testing in Lyme disease: a comparison of results in four laboratories. JAMA 1989, 262:3431.
98. Coyle PK, Schutzer SE, Deng Z, et al. Detection of Borrelia burgdorferi-specific antigen in antibody-negative cerebrospinal fluid in neurologic Lyme disease. Neurology 1995, 45:2010.
99. Schutzer SE, Coyle PK, Reid P, et al. Borrelia burgdorferi-specific immune complexes in acute Lyme disease. JAMA 1999, 282:1942.
100. Vital Events and Reportable Diseases and Conditions, 1979-1998 1999, Vol 18:8-12. City Health Information, NYC Department of Health, New York.
101. American College of Physicians Guidelines for laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 1997, 127:1106.
102. Dressler F, Whalen JA, Reinhardt BN, et al. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993, 167:392.
103. Stiernstedt GT, Granstrom M, Hederstedt B, et al. Diagnosis of spirochetal meningitis by enzyme-linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid. J Clin Microbiol 1985, 21:819.
104. Hammers-Berggren S, Hansen K, Lebech AM, et al. Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology 1993, 43:169.
105. Sigal LH, Zahradnik JM, Lavin P, et al. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. N Engl J Med 1998, 339:216.
106. Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi. N Engl J Med 1998, 339:209.
107. Dattwyler RJ, Luft BJ, Kunkel MJ, et al. Ceftriaxone compared with doxycycline for the treatment of acute. N Engl J Med 1997, 337:289.
108. Steere AC, Levin RE, Molloy PJ, et al. Treatment of Lyme arthritis. Arthritis Rheum 1994, 37:878.
109. Karlsson M, Hammers-Berggren S, Lindquist L, et al. Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 1994, 44:1203.
110. Anonymous Treatment of Lyme disease. Med Lett 2000, 42:37.
111. Dattwyler RJ, Halperin JJ, Volkman DJ, et al. Treatment of late Lyme disease. Lancet 1988, 1:1191.
112. Dattwyler RJ, Luft BJ, Maladorno D, et al: Treatment of late Lyme disease-a comparison of 2 weeks vs 4 weeks of ceftriaxone. p. 186. In VII International Congress on Lyme Borreliosis, San Francisco, CA, 1996.
113. Klempner M, Hu L, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001, 85:345.
114. Krupp LB, Hyman LG, Grimson R, et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 2003, 60:1923.
115. Seltzer EG, Gerber MA, Cartter ML, et al. Long-term outcomes of persons with Lyme disease. JAMA 2000, 283:609.
116. Shadick NA, Phillips CB, Sangha O, et al. Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Ann Intern Med 1999, 131:919.